Biocon Limited — Credit Ratings, 16-12-2025: Credit Rating

ICRA has reaffirmed Biocon's credit ratings for its Rs. 450 Cr Long-term/Short-term Unallocated facilities at [ICRA]AA+ (Stable) and [ICRA]A1+. This follows Biocon's plan to make Biocon Biologics a wholly-owned subsidiary via a $1.17 billion transaction. This move is seen as strategically positive, aiming to simplify the group structure and achieve operational synergies. Funding involves a share swap and cash payment, with deleveraging plans relying on a Qualified Institutional Placement.